|1.||Kitagawa, K: 2 articles (08/2001 - 04/2001)|
|2.||Hattori, N: 2 articles (08/2001 - 04/2001)|
|3.||Zeng, X T: 2 articles (08/2001 - 04/2001)|
|4.||Inagaki, C: 2 articles (08/2001 - 04/2001)|
|5.||Yagyu, K: 2 articles (08/2001 - 04/2001)|
|6.||Yagyu, Kyoko: 1 article (12/2002)|
|7.||Inagaki, Chiyoko: 1 article (12/2002)|
|8.||Zhang, Nan-Yan: 1 article (12/2002)|
|9.||Wu, Bo: 1 article (12/2002)|
|10.||Kitagawa, Kaori: 1 article (12/2002)|
|1.||Alzheimer Disease (Alzheimer's Disease)
04/01/2001 - "(4) In the brains of patients with Alzheimer's disease (AD), where phosphatidylinositol 4-kinase activity is reduced, Cl(-)-ATPase activity was also reduced. "
10/02/1998 - "The enzyme activities and the protein levels of Cl(-)-ATPase and Na+/K(+)-ATPase were examined in Alzheimer's disease (AD) brains. "
08/01/2001 - "To test its pathophysiological changes in a phosphatidylinositol (PI) metabolism disorder, the effects of neurotoxic factors in Alzheimer's disease (AD), amyloid beta proteins (Abetas), on the Cl(-)-ATPase activity were examined using primary cultured rat hippocampal neurons. "
12/20/2002 - "We previously reported that low concentrations (1-10 nM) of amyloid beta proteins (Abetas, Abeta1-42, Abeta25-35), the neurotoxic peptides in Alzheimer's disease, reduced Cl- -ATPase activity in cultured rat hippocampal neurons without any changes in the activities of Na+/K+-ATPase or anion-insensitive Mg(2+)-ATPase, and decreased PI, PIP, and PIP2 levels in neuronal plasma membranes (Journal of Neurochemistry 2001, 78, 569-579). "
|2.||Neurodegenerative Diseases (Neurodegenerative Disease)
|3.||Tonic-Clonic Epilepsy (Epilepsy, Tonic Clonic)
|2.||Adenosine Triphosphatases (ATPase)
|3.||1-Phosphatidylinositol 4-Kinase (1 Phosphatidylinositol 4 Kinase)
|6.||Ethacrynic Acid (Etacrynic Acid)